Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Data Validation
1.5 COVID-19 impact analysis at regional level
1.6 Data Sources
1.6.1 Secondary
1.6.1.1 Paid sources
1.6.1.2 Public sources
1.6.2 Primary
Chapter 2 Executive Summary
2.1 Therapeutic respiratory devices industry 360° synopsis, 2018 – 2032 (USD Million)
2.2 Business trends
2.3 Regional trends (USD Million & Units)
2.4 Product trends (USD Million & Units)
2.5 Application trends
2.6 End-use trends
Chapter 3 Therapeutic Respiratory Devices Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of respiratory diseases in developing countries
3.2.1.2 Increasing geriatric population globally
3.2.1.3 Technological innovation in developed countries
3.2.2 Industry pitfalls & challenges
3.2.2.1 Lack of patient compliance
3.2.2.2 Cost burden of respiratory diseases
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By application
3.3.3 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Technology landscape
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive dashboard, 2022
4.4 Company market share analysis, 2022
4.5 Vendor matrix analysis, 2022
4.6 Competitive analysis of major market players
4.7 Competitive positioning matrix
4.8 Strategic outlook matrix
Chapter 5 Therapeutic Respiratory Devices Market Size and Forecast, By Product (USD Million & Units)
5.1 Key trends, by product
5.2 Positive airway pressure (PAP) devices
5.2.1 Continuous positive airway pressure (CPAP) devices
5.2.2 Auto-titrating positive airway pressure (APAP) devices
5.2.3 Bi-level positive airway pressure (BiPAP) devices
5.3 Oxygen concentrators
5.3.1 Fixed oxygen concentrators
5.3.2 Portable oxygen concentrators
5.4 Ventilators
5.4.1 Adult ventilators
5.4.2 Neonatal ventilators
5.5 Inhalers
5.5.1 Metered dose inhaler (MDI)
5.5.2 Dry powder inhaler (DPI)
5.5.3 Soft mist inhaler (SMI)
5.6 Nebulizer
5.6.1 Compressor-based nebulizers
5.6.2 Piston-based hand-held nebulizers
5.6.3 Ultrasonic nebulizers
5.7 Humidifiers
5.7.1 Heated Humifidifiers
5.7.2 Passover humidifiers
5.7.3 Integrated humidifiers
5.7.4 Built-in humidifiers
5.7.5 Standalone humidifiers
5.8 Others
Chapter 6 Therapeutic Respiratory Devices Market Size and Forecast, By Application (USD Million)
6.1 Key trends, by application
6.2 COPD
6.3 Obstructive sleep apnea
6.4 Asthma
6.5 Respiratory distress syndrome
6.6 Cystic fibrosis
6.7 Others
Chapter 7 Therapeutic Respiratory Devices Market Size and Forecast, By End-use (USD Million)
7.1 Key trends, by end-use
7.2 Hospitals
7.3 Homecare settings
7.4 Emergency centers
Chapter 8 Therapeutic Respiratory Devices Market Size and Forecast, By Region (USD Million & Units)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.4 Asia Pacific
8.4.1 China
8.4.2 India
8.4.3 Japan
8.4.4 Australia
8.4.5 South Korea
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
Chapter 9 Company Profiles
9.1 Breas Medical AB
9.2 Drägerwerk AG & Co. KGaA
9.3 Fisher & Paykel Healthcare Limited
9.4 GE Healthcare
9.5 Hamilton Medical
9.6 Hill-Rom Services Inc. (Baxter)
9.7 Invacare Corporation
9.8 Koninklijke Philips N.V.
9.9 Medtronic
9.10 ResMed Inc.
9.11 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
9.12 ICU Medical
9.13 VYAIRE MEDICAL, INC.
